Details
Stereochemistry | ACHIRAL |
Molecular Formula | C19H24N4O2.2CH4O3S |
Molecular Weight | 532.631 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.CS(O)(=O)=O.NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
InChI
InChIKey=WRXSODAXJSKMAW-UHFFFAOYSA-N
InChI=1S/C19H24N4O2.2CH4O3S/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23;2*1-5(2,3)4/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23);2*1H3,(H,2,3,4)
Molecular Formula | C19H24N4O2 |
Molecular Weight | 340.4195 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | CH4O3S |
Molecular Weight | 96.106 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:42 UTC 2023
by
admin
on
Fri Dec 15 15:13:42 UTC 2023
|
Record UNII |
863QBB4D0A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
72196
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
C200703
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
863QBB4D0A
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
229-898-4
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
SUB32093
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
100000124424
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
6823-79-6
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
DBSALT002232
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
DTXSID50987751
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | |||
|
m8497
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | Merck Index | ||
|
PENTAMIDINE MESYLATE
Created by
admin on Fri Dec 15 15:13:42 UTC 2023 , Edited by admin on Fri Dec 15 15:13:42 UTC 2023
|
PRIMARY | Description: A white or light pink, granular powder; almost odourless. Solubility: Slightly soluble in water and ethanol (~750 g/l) TS; practically insoluble in ether R and acetone R. Category: Antitrypanosomal drug; antileishmaniasis drug. Storage: Pentamidine mesilate should be kept in a well-closed container.Definition: Pentamidine mesilate contains not less than 98.5% and not more than 102.5% of C19H24N4O2,2CH4O3S, calculatedwith reference to the dried substance. Manufacture: The production method must be evaluated to determine the potential for formation of alkyl mesilates, which isparticularly likely to occur if the reaction medium contains lower alcohols. Where necessary, the production method is validated todemonstrate that alkyl mesilates are not detectable in the final product. |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |